Skip to main content
. 2022 Mar 2;37(11):2547–2557. doi: 10.1007/s00467-022-05492-7

Table 1.

Randomized controlled trials of ferric citrate in adult patients with non-dialysis-dependent CKD. FC, ferric citrate; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; TSAT, transferrin saturation; FGF23, fibroblast growth factor 23; LS, least squares

Study Study details Study parameters Effects of ferric citrate p-value for between-group differences
Yokoyama et al. [53]

FC (n = 57) vs. placebo (n = 29)

12-week duration

Inclusive of CKD stages 3–5 (mean eGFR 9 ml/min/1.73 m2)

Mean age 65 years

Phosphate

TSAT

Ferritin

Hemoglobin

FGF23

Decreased from mean 5.7 to 4.4 mg/dl

Increased from mean 27 to 44%

Increased from mean 69 to 204 ng/ml

Increased from mean 10.3 to 10.7 g/dl

Decreased from median 453 to 209 pg/ml

 < 0.001

 < 0.001

 < 0.001

0.23

 < 0.001

Block et al. [54]

FC (n = 72) vs. placebo (n = 69)

12-week duration

Inclusive of CKD stages 3–5 (mean eGFR 24 ml/min/1.73 m2)

Mean age 65 years

Phosphate

TSAT

Ferritin

Hemoglobin

FGF23

Decreased from mean 4.5 to 3.9 mg/dl

Increased from mean 22 to 32%

Increased from mean 116 to 189 ng/ml

Increased from mean 10.5 to 11.0 g/dl

Decreased from median 159 to 105 pg/ml

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.02

Fishbane et al. [55]

FC (n = 117) vs. placebo (n = 116)

16-week duration

Inclusive of CKD stages 3–5 (mean eGFR 29 ml/min/1.73 m2)

Mean age 65 years

Phosphate

TSAT

Ferritin

Hemoglobin

FGF23

Mean relative change vs. placebo of − 0.2 mg/dl

Mean relative change vs. placebo of + 18%

Mean relative change vs. placebo of + 170 ng/ml

Mean relative change vs. placebo of + 0.8 g/dl

Decreased from median 134 to 105 pg/ml

0.02

 < 0.001

 < 0.001

 < 0.001

 < 0.001

Block et al. [56]

FC (n = 133) vs. usual care (n = 66)

36-week duration

Inclusive of eGFR < 20 ml/min/1.73 m2 (mean eGFR 14 ml/min/1.73 m2)

Mean age 62 years

Phosphate

TSAT

Ferritin

Hemoglobin

FGF23

Lower LS mean vs. usual care (4.2 vs. 4.6 mg/dl)

Increased with FC, unchanged with usual care

Increased with FC, unchanged with usual care

Increased with FC, decreased with usual care

Unchanged with FC, increased with usual care

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001